News
-
Artificial Intelligence, Health Tech, Providers, Startups
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Here is a list of some of the most notable funding round announcements that took place this March in the provider technology space.
-
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its pipeline, including a lead program on track to report preliminary data later this year.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Health Tech, Hospitals, Providers
Why Mass General Brigham Wants to Move 10% of Patient Care to the Home
At HIMSS24, Heather O’Sullivan, Mass General Brigham’s president of healthcare at home, said that the health system wants to move 10% of all its medical patients to the home. She argued that there is “no greater model of care for being patient-centric,” and highlighted the care modality’s ability to alleviate burnout for some healthcare workers.
-
FOLX Health, Crisis Text Line Partner To Support LGBTQIA+ Community
Through a new partnership, FOLX members can gain access to crisis counselors through Crisis Text Line in addition to their support from the FOLX Health care team.
-
Devices & Diagnostics, BioPharma
Novocure’s Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain
Novocure said its “Tumor Treating Fields” met the main goal of a pivotal study enrolling non-small cell lung cancer patients with brain metastases. However, results for the electricty-based treatment fell short of statistical significance on several secondary endpoints.
-
Improving Interoperability and Health Equity With Health Information Exchange Networks
In a webinar sponsored by DocuSign, scheduled for April 16 at 1 pm ET, DocuSign will discuss how its pilot project with Velatura will streamline the patient consent form capture process for protected health information (PHI) and improve efficiency for providers.
-
MedCity Pivot: A Conversation About Wearable Robots with Scott Davis
Scott Davis is the CEO of Ekso Bionics, an innovative medical device company making wearable exoskeletons for use in construction but perhaps, more importantly, to help people contending with spinal cord injury.
-
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval
Merck drug Winrevair is the first in a new class of pulmonary arterial hypertension therapies that address a key signaling pathway behind the disease. The drug comes from Merck’s $11.5 billion acquisition of Acceleron Pharma.
-
Artificial Intelligence, Health Tech, Hospitals, Providers
UNC Health CMIO: Clinicians and AI Must ‘Synergistically Work Together’
AI is meant to have a synergistic relationship with clinicians rather than replace them, pointed out David McSwain, chief medical information officer at UNC Health, during an interview at HIMSS24. In his view, both humans and AI are fallible, but their errors are usually of a different type — so both should be working together to reduce the overall error rate.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
AbbVie Gets Another Ulcerative Colitis Contender via $137M Landos Acquisition
AbbVie is acquiring Landos Biopharma, whose lead drug is a small molecule that takes a novel approach to treating ulcerative colitis. Preliminary proof-of-concept data from a Phase 2 study are expected later this year.
-
Menopause Brain Fog or Dementia? Midi Health, Neurotrack Team Up To Offer Screening
Many women going through menopause suffer brain fog, but some may be worried about a more serious cognitive condition like dementia. Because of this, Midi Health and Neurotrack partnered to offer a cognitive assessment to patients.
-
Artificial Intelligence, Health Tech, Hospitals, Providers
There’s a Crucial Part of Tech Pilot Design That Many Health Systems Forget, Geisinger Exec Says
During an interview this month at HIMSS24, David Vawdrey — Geisinger’s chief data and informatics officer — said health systems should spend more time designing their plan for evaluating success when it comes to tech pilots.
-
Novo Nordisk Expands Cardio Reach by Buying Heart Drugs Biotech Cardior
Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardior Pharmaceuticals adds a novel RNA-based therapy that is a potential heart failure treatment.
-
MedCity INVEST Pitch Perfect Judge Shares Healthcare Investment Perspective
David Kereiakes, managing partner with Windham Venture Partners, shared his perspective of the health tech sector and investment trends he’s seeing.
-
Health Tech, Providers, Startups
How Can Digital Health Startups Stand Out In Today’s Landscape?
During a recent panel, Flare Capital Partners’ Michael Greeley and Mount Sinai’s Robbie Freeman shared some attributes that they think stand out among digital health startups that have found success in today’s environment.
-
Report: Digital Diabetes Management Tools Fall Short
A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don’t provide meaningful clinical benefits and increase healthcare spending.
-
Vitality in the Supply Chain: The Limitless Potential of ATMPs
The “holy grail” of ATMP-based treatments is to provide cures for some of the world’s most debilitating disease states, but for this to occur, a unified front is needed to democratize these therapies – collaboration from industry, academia, supply chain and, indeed, clinicians and hospitals is paramount to ensuring safe manufacturing and transit.
-
Pharma, Artificial Intelligence, BioPharma
Survey: Pharma Commercial Teams Want More Data Analytics Solutions
Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based pharma companies. The survey was conducted in late 2023 and results were reported this month.